NEW YORK & NASHVILLE, Tenn.--(BUSINESS WIRE)--The Mount Sinai Health System announced today that it has partnered with Contessa Health, an innovative health care company that manages acute-care services at home through prospective bundled payment arrangements, to extend Mount Sinai’s existing hospital-level care at home program, known as the Mobile Acute Care Team (MACT), to new markets.
As part of Mount Sinai’s commitment to keeping communities healthy and out of the hospital, the Health System initially launched the program in 2014 with the support of a multi-year innovation award from the Centers for Medicare and Medicaid Services. Through the program, eligible patients receive hospital-level care for selected conditions in the comfort of their homes, in lieu of a hospital stay, from Mount Sinai providers. The Mount Sinai program provides comprehensive treatment of acute illness in the patient’s home under the supervision of physicians who have extensive experience in the management of illness both within and outside the hospital setting.
Currently, Mount Sinai’s program is available to Medicare patients with specific acute medical conditions who would otherwise be admitted to a hospital within the Mount Sinai Health System. The partnership with Contessa Health will allow Mount Sinai to scale this program to include patients with different types of health insurance and a broader range of clinical conditions.
“We just treated our 600th patient since the program commenced in November of 2014,” stated Linda V. DeCherrie, MD, Clinical Director of MACT. “Our data has shown that we can reduce 30-day hospital readmissions, earn high patient satisfaction, and reduce the cost of care, all while providing hospital-level care in a more efficient and safer setting.”
Contessa Health is an innovator in creating and managing value-based care models, operating through a prospective bundled payment program where a fixed price for services is established in advance to deliver all services within an episode of care. Contessa’s proprietary claims system, coupled with its integrated clinical care model, will help Mount Sinai to broaden its existing program, bringing hospital-level care into homes of patients throughout the area. Contessa has implemented a hospital-level care at home program with Marshfield Clinic Health System in Wisconsin.
In addition, Mount Sinai will work with Contessa to add an option for post-surgical care at home. This will permit eligible patients to recover from surgeries that would normally require an inpatient hospital stay (such as total joint replacements) in the comfort of their own homes.
While delivering physician-led hospital-level care in the home is not new, the collaboration between Mount Sinai and Contessa Health is new and unique to the health care landscape.
“This partnership with Contessa Health is critical to the overall transformation of our health system, underscoring Mount Sinai’s commitment to creating an innovative health care system that emphasizes outpatient, ambulatory, and home-based care with remote monitoring capabilities,” stated Niyum Gandhi, Executive Vice President and Chief Population Health Officer for Mount Sinai Health System. “We are excited to work with Contessa to expand the reach of this program to benefit more patients who would have otherwise been hospitalized.”
“We are thrilled to partner with Mount Sinai to achieve the mutual goal of lowering costs and improving quality of care for patients,” said Travis Messina, CEO of Contessa Health. “Mount Sinai’s clinical outcomes speak for themselves, and we are excited to help accelerate their program so that more patients have access to a health care model that truly is changing the delivery of care.”
“Our team is pleased to have joined forces with Contessa to expand this innovative model of patient care to a broader market,” said Erik Lium, PhD, Senior Vice President at Mount Sinai Innovation Partners.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Health System physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the “Honor Roll” of best hospitals in America, ranked No. 15 nationally in the 2016-2017 “Best Hospitals” issue of U.S. News & World Report.
The Mount Sinai Hospital is also ranked as one of the nation’s top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke’s, and Mount Sinai West are ranked regionally. Mount Sinai’s Kravis Children’s Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in “Best Children’s Hospitals.”
About Contessa Health
Contessa Health is a leading innovative healthcare company that operates patient-centered prospective bundled payment programs by partnering with payers and providers. We create and manage episodic risk arrangements by leveraging managed services, our proprietary analytics and claims platform, ContradoClaim®, and evidence-based clinical protocols. Contessa Health aims to make the healing experience enjoyable, both for those receiving care and for those delivering care. With our clinical model, ContessaCare™, providers can deliver hospital-level care to patients in the comforts of their homes without an administrative burden.
For more information, visit www.contessahealth.com.
About Mount Sinai Innovation Partners (MSIP)
MSIP facilitates the real-world application and commercialization of Mount Sinai discoveries and the development of research partnerships with industry. MSIP is responsible for the full spectrum of commercialization activities required to bring the Icahn School of Medicine’s inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, while also engaging commercial and non-profit relationships for sponsored research, material transfer, and confidentiality. For more information, visit www.ip.mountsinai.org.
The project described was supported by Grant Number 1C1CMS331334 from the U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services. The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. Department of Health and Human Services or any of its agencies. The research presented was conducted by the awardee. Findings may or may not be consistent with or confirmed by the findings of the independent evaluation contractor.